Pulling SEC filings + quote and writing the call…

QUAKER CHEMICAL CORP
Next earnings Jul 29, 2026 · consensus $1.63 EPS, $513M rev
Last earnings +2.0% on 2026-04-30
Specialty-chemical leader at a cyclical trough: GAAP net loss but $136M operating cash flow; cheapish at 1.4x sales, no clear catalyst.
Revenue $1.89B · FY2025
Quaker Houghton (KWR) is the self-described leader in industrial process fluids, and its FY2025 numbers read like a quality franchise caught in a cyclical trough rather than a broken business. Revenue was roughly flat at $1.89B (+2.7%), continuing a four-year plateau around $1.8–1.95B, and the headline GAAP net loss of -$2.49M (vs. +$117M in FY2024) looks far worse than the underlying engine. Operating income was still positive at $53.0M and gross margin held at 36.0%, while operating cash flow came in at a healthy $136M. The gap between $53M of operating income and a net loss points to below-the-line drag — rising interest on a debt load that grew 24.7% to $835M long-term, plus the 'higher cash outflows from restructuring activities' management cites in the MD&A. This is margin compression (operating margin 2.8%, down from a 72.8% drop in operating income), not revenue collapse.
The MD&A frames the weakness clearly: 'challenging end market conditions, particularly in the Americas and EMEA segments,' partly offset by Asia/Pacific volume growth and 'new business wins across all segments.' The Risk Factors underline why this matters — demand is derived from cyclical steel, automotive, aerospace, aluminum and durable-goods customers, and the company admits it has 'limited ability to adjust our costs contemporaneously with changes in sales.' That operating leverage is exactly what turned a modest revenue softening into an earnings air-pocket. Customer concentration is low (top five ~11%, largest ~3%), so this is macro/cyclical, not idiosyncratic.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 29, 2026, 11:34 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $1.76B | $1.94B | $1.95B | $1.84B | $1.89B |
| Gross profit | $595M | $613M | $706M | $686M | $679M |
| Operating income | $150M | $52.3M | $214M | $195M | $53.0M |
| Net income | $121M | -$15.9M | $113M | $117M | -$2.49M |
| Diluted EPS | $6.77 | -$0.89 | $6.26 | $6.51 | -$0.14 |
| Net margin | 6.9% | -0.8% | 5.8% | 6.3% | -0.1% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Annual meeting vote results plus a board/officer change; routine governance update
Q1 2026 10-Q: soft end markets persist, new business wins partly offsetting
Q1 2026 10-Q: soft end markets persist, new business wins partly offsetting
Entered a material financing agreement, adding debt as LT borrowings rose ~25%
Disclosed a leadership/officer change; no financial impact stated
FY2025 10-K: net loss of $2.5M, operating income down 73%, debt up 25%
FY2025 10-K: net loss of $2.5M, operating income down 73%, debt up 25%
Q3 2025 10-Q: lower operating earnings on challenging Americas/EMEA conditions
Sources: SEC EDGAR (CIK 0000081362, latest 10-Q filed 2026-04-30) · EODHD · Proprietary analysis · as of 6/30/2026, 3:34:34 AM.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2026-06-15 | Coler Thomas EVP, CFO | Exercise | 2.35K | |
| 2026-06-15 | Coler Thomas EVP, CFO | Exercise | 68.00 | |
| 2026-06-15 | Coler Thomas EVP, CFO | Tax | 741.00 @ $144.46 | $107K |
| 2026-06-01 | Foufopoulos - De Ridder Lucrece Director | Award | 413.00 @ $145.24 | $60.0K |
| 2026-06-01 | Foufopoulos - De Ridder Lucrece Director | Tax | 124.00 @ $145.24 | $18.0K |
| 2026-06-01 | DOUGLAS MARK Director | Award | 766.00 | |
| 2026-06-01 | Shaller Russell Director | Award | 413.00 @ $145.24 | $60.0K |
| 2026-05-31 | Foufopoulos - De Ridder Lucrece Director | Exercise | 1.20K | |
| 2026-05-31 | Foufopoulos - De Ridder Lucrece Director | Exercise | 18.00 | |
| 2026-05-31 | Foufopoulos - De Ridder Lucrece Director | Tax | 365.00 @ $143.53 | $52.4K |
| 2026-05-31 | DOUGLAS MARK Director | Exercise | 1.20K | |
| 2026-05-31 | DOUGLAS MARK Director | Exercise | 18.00 |
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.